Deals

Deals (w/e 4/10/26)

Deals

Blackstone and TPG complete $18.3bn Hologic take-private. Women's health, diagnostics, and medical devices. CEO Steve MacMillan retired the day the deal closed after 12 years running the company. He turned Hologic from a struggling business into a COVID-era diagnostics powerhouse and then a consistent grower. The take-private lets the new owners run the next phase without quarterly earnings theatre. When the CEO walks out the same door as the public listing, the thesis is clear: this is a rebuild, not a continuation. MASSDEVICE

Apollo hired three managing directors. Carlyle supplied one of them.

Apollo hired three managing directors, one of them from Carlyle. Advent's head of tech strategy now works at the OpenAI venture Advent helped fund.

Advent sold its last CCC shares at $7.79. GTCR will pay $7.75.

GTCR and Elliott are paying $7.75 a share for CCC. Advent sold its final stake last November at $7.79, down from a $10 SPAC-era price.

Thoma Bravo's Proofpoint pays 53 times free cash flow for Varonis

Proofpoint will pay $49.75 a share for Varonis, 52% above the June close. The multiple is 53 times free cash flow, and the first-half cash flow fell.

EQT's fee-generating assets rose €40bn in a quarter. Coller was €34bn.

Fee-generating assets rose €40bn in the quarter. Strip out the Coller acquisition and the gain is about €6bn.

Deals

Read more

Apollo hired three managing directors. Carlyle supplied one of them.

Advent sold its last CCC shares at $7.79. GTCR will pay $7.75.

Thoma Bravo's Proofpoint pays 53 times free cash flow for Varonis

EQT's fee-generating assets rose €40bn in a quarter. Coller was €34bn.